JAK2 and breast carcinoma: PVT1 is a long noncoding RNA that is commonly overexpressed in breast cancer and has been implicated in the regulation of MYC oncogene [43,44], while JAK2 is a tyrosine kinase activating cancer-driving JAK/STAT signaling pathway [45].